Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 Actavis
  • 3.1.2 Company Information
  • 3.1.2 Product Specifications
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.2 Chugai Pharmaceutical
  • 3.2.1 Company Information
  • 3.2.2 Product Specifications
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.3 Ferring International Center
  • 3.3.1 Company Information
  • 3.3.2 Product Specifications
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.4 Synergy Pharmaceuticals
  • 3.4.1 Company Information
  • 3.4.2 Product Specifications
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.5 Pfizer
  • 3.5.1 Company Information
  • 3.5.2 Product Specifications
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.6 GlaxoSmithKline
  • 3.6.1 Company Information
  • 3.6.2 Product Specifications
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.7 GlaxoSmithKline
  • 3.7.1 Company Information
  • 3.7.2 Product Specifications
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.8 Sanofi
  • 3.8.1 Company Information
  • 3.8.2 Product Specifications
  • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.9 Bayer
  • 3.9.1 Company Information
  • 3.9.2 Product Specifications
  • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.10 Salix Pharmaceuticals
  • 3.10.1 Company Information
  • 3.10.2 Product Specifications
  • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.11 Sucampo Pharmaceuticals
• 3.12 Ironwood Pharmaceuticals
• 3.13 Progenics Pharmaceuticals

4 Major Application

• 4.1 Hospitals & Clinics
  • 4.1.1 Overview
  • 4.1.2 Hospitals & Clinics Market Size and Forecast
• 4.2 Ambulatory Surgical Centres
  • 4.2.1 Overview
  • 4.2.2 Ambulatory Surgical Centres Market Size and Forecast
• 4.3 Long Term Care Centres
  • 4.3.1 Overview
  • 4.3.2 Long Term Care Centres Market Size and Forecast
• 4.4 Others
  • 4.4.1 Overview
  • 4.4.2 Others Market Size and Forecast

5 Market by Type

• 5.1 Lubiprostone
  • 5.1.1 Overview
  • 5.1.2 Lubiprostone Market Size and Forecast
• 5.2 Linaclotide
  • 5.2.1 Overview
  • 5.2.2 Linaclotide Market Size and Forecast
• 5.3 Others
  • 5.3.1 Overview
  • 5.3.2 Others Market Size and Forecast

6 Conclusion

Summary
The global Chronic Idiopathic Constipation (CIC) Drugs market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Actavis
    Chugai Pharmaceutical
    Ferring International Center
    Synergy Pharmaceuticals
    Pfizer
    GlaxoSmithKline
    GlaxoSmithKline
    Sanofi
    Bayer
    Salix Pharmaceuticals
    Sucampo Pharmaceuticals
    Ironwood Pharmaceuticals
    Progenics Pharmaceuticals
Major applications as follows:
Hospitals & Clinics
    Ambulatory Surgical Centres
    Long Term Care Centres
    Others
Major Type as follows:
Lubiprostone
    Linaclotide
    Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa